SFX by Ex Libris Inc.

Title:	Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene
Source:	Nature Genetics [1061-4036] Meindl, Alfons yr:2010

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Vaz, F. "Mutation of the RAD51C gene in a Fanconi anemia-like disorder." Nature Genetics 42.5 (2010): 406-409.
description	2.	Thompson, Ella R. "Analysis of RAD51C germline mutations in highârisk breast and ovarian cancer families and ovarian cancer patients." Human mutation 33.1 (2012): 95-95.
description	3.	Loveday, C. "Germline mutations in RAD51D confer susceptibility to ovarian cancer." Nature Genetics 43.9 (2011): 879-882.
description	4.	Pandolfi, Pier P. "Subtle variations in Pten dose determine cancer susceptibility." Nature Genetics 42.5 (2010): 454-458.
description	5.	Moynahan, M E E. "BRCA2 is required for homology-directed repair of chromosomal breaks." Molecular cell 7.2 (2001): 263-72.
description	6.	Buchen, L. "Neuroscience: Illuminating the brain." Nature 465.7294 (2010): 26-28.
description	7.	Zhang, F. "PALB2 Functionally Connects the Breast Cancer Susceptibility Proteins BRCA1 and BRCA2." Molecular cancer research 7.7 (2009): 1110-1118.
description	8.	Sobol, H. "Disclosure to the family of breast/ovarian cancer genetic test results: patient's willingness and associated factors." American journal of medical genetics 94.1 (2000): 13-18.
description	9.	Liu, Y. "RAD51C is required for Holliday junction processing in mammalian cells." Science 303.5655 (2003): 243-6.
description	10.	Moynahan, M E E. "Brca1 Controls Homology-Directed DNA Repair." Molecular cell 4.4 (1999): 511-518.
description	11.	Zhang, S. "Identification and characterization of ovarian cancer-initiating cells from primary human tumors." Cancer research 68.11 (2008): 4311-4320.
description	12.	Chen, Z. "Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis." Nature 436.7051 (2005): 725-30.
description	13.	Meindl, A. "Germline RAD51C mutations confer susceptibility to ovarian cancer." Nature Genetics 44.5 (2012): 476-476.
description	14.	Johnson, J. "Mutation analysis of RAD51L1 (RAD51B/REC2) in multiple-case, non-BRCA1/2 breast cancer families." Breast cancer research and treatment 129.1 (2011): 255-263.
description	15.	Barrett, David C. "Genome-wide association defines more than 30 distinct susceptibility loci." Nature genetics 40.8 (2008): 955-507.
description	16.	Rebbeck, Timothy R. "Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1 Interacting Genes." Cancer research 71.17 (2011): 5792-5805.
description	17.	Evans, David M. "Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility." Nature Genetics 43.8 (2011): 761-767.
description	18.	Lin, H. "Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence." Nature 464.7287 (2010): 374-379.
description	19.	Mendes-Pereira, A. "Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors." EMBO Molecular Medicine 1.6-7 (2009): 315-322.
description	20.	Sharma, S. "Polypyrimidine tract binding protein controls the transition from exon definition to an intron defined spliceosome." Nature structural & molecular biology 15.2 (2008): 183-191.